High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Coronary Stent Revascularization-Reference-Cited by-同舟云学术

High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Coronary Stent Revascularization

Published:2014-05-27 Issue:21 Volume:129 Page:2136-2143
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Montalescot Gilles¹,Rangé Grégoire¹,Silvain Johanne¹,Bonnet Jean-Louis¹,Boueri Ziad¹,Barthélémy Olivier¹,Cayla Guillaume¹,Belle Loic¹,Van Belle Eric¹,Cuisset Thomas¹,Elhadad Simon¹,Pouillot Christophe¹,Henry Patrick¹,Motreff Pascal¹,Carrié Didier¹,Rousseau Hélène¹,Aubry Pierre¹,Monségu Jacques¹,Sabouret Pierre¹,O’Connor Stephen A.¹,Abtan Jérémie¹,Kerneis Mathieu¹,Saint-Etienne Christophe¹,Beygui Farzin¹,Vicaut Eric¹,Collet Jean-Philippe¹

Affiliation:

1. From the ACTION Study Group, Institut de Cardiologie (AP-HP), INSERM UMRS 1166, Université Paris 6, Paris, France (G.M., J.S., O.B., P.S., S.A.O., M.K., J.-P.C.); Hôpital Louis Pasteur, Le Coudray, France (G.R.); Hôpital de la Timone, Marseille, France (J.-L.B., T.C.); CH de Bastia, Bastia, France (Z.B.); CHU Carémeau, Nîmes, France (G.C.); CH de la Région Annecienne, Annecy, France (L.B.); Hôpital Cardiologique, Lille, France (E.V.B.); CH de Lagny, Marne-la-Vallée, France (S.E.); Clinique Sainte...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention

2. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study.;Trenk D;J Am Coll Cardiol,2012

3. Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting

4. Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: rationale and design of the assessment with a double randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and clopidogrel after DES implantation, and (2) treatment interruption versus continuation, 1 year after stenting (ARCTIC) study.;Collet JP;Am Heart J,2011

5. Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative platelet reactivity over time in patients undergoing vascular surgery: An observational pilot study;PLOS ONE;2024-06-26

2. Remembering our friend Jean-Philippe Collet: a giant in cardiology, a gentleman in life;Minerva Cardiology and Angiology;2024-06

3. Clopidogrel resistance and its relevance: Current concepts;Journal of Family Medicine and Primary Care;2024-06

4. Inflammation modifies the platelet reactivity among thrombocytopenia patients undergoing percutaneous coronary intervention;Platelets;2024-04-24

5. Acute Coronary Syndrome;Primary Care: Clinics in Office Practice;2024-03